# X4 Pharmaceuticals (XFOR) — Analyst Forecast

XFOR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/xfor/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 5 | 0 | 0 | 5 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Jul 10, 2026 | Wells Fargo | Initiated Coverage | Overweight | $11.00 |
| Jun 2, 2026 | Leerink Partners | Initiated Coverage | Outperform | $12.00 |
| Mar 9, 2026 | Guggenheim | Initiated Coverage | Buy | $12.00 |
| Dec 5, 2025 | Stifel | Maintained | Buy | $10.00 |
| Nov 10, 2025 | HC Wainwright & Co. | Maintained | Buy | $5.00 |
| Aug 29, 2025 | Stifel | Maintained | Buy | $9.00 |
| Aug 13, 2025 | HC Wainwright & Co. | Maintained | Buy | $3.50 |
| May 2, 2025 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Mar 27, 2025 | HC Wainwright & Co. | Maintained | Buy | $1.50 |
| Mar 26, 2025 | Cantor Fitzgerald | Maintained | Overweight | $3.00 |
| Feb 7, 2025 | HC Wainwright & Co. | Maintained | Buy | $1.50 |
| Jan 14, 2025 | HC Wainwright & Co. | Maintained | Buy | $1.50 |
| Nov 14, 2024 | Stifel | Maintained | Buy | $4.00 |
| Nov 14, 2024 | HC Wainwright & Co. | Maintained | Buy | $1.50 |
| Jun 28, 2024 | HC Wainwright & Co. | Maintained | Buy | $5.00 |
| May 31, 2024 | Cantor Fitzgerald | Maintained | Overweight | $5.00 |
| Apr 30, 2024 | HC Wainwright & Co. | Maintained | Buy | $5.00 |
| Mar 22, 2024 | HC Wainwright & Co. | Maintained | Buy | $3.00 |
| Dec 12, 2023 | B. Riley Securities | Downgraded | Buy → Neutral | $1.00 |
| Aug 11, 2023 | HC Wainwright & Co. | Maintained | Buy | $3.00 |

## Frequently Asked Questions

### Is XFOR a buy, sell, or hold?

Analysts covering X4 Pharmaceuticals currently average a Buy rating: 5 buy, 0 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on XFOR?

On Jul 10, 2026, Wells Fargo initiated coverage of X4 Pharmaceuticals at Overweight with a price target of $11.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).